138 related articles for article (PubMed ID: 15173058)
1. Statins as immunomodulatory agents.
Mach F
Circulation; 2004 Jun; 109(21 Suppl 1):II15-7. PubMed ID: 15173058
[TBL] [Abstract][Full Text] [Related]
2. In vivo suppression of major histocompatibility complex class II expression on porcine vascular endothelial cells by an HMG-CoA reductase inhibitor.
Geissler I; Collins L; Schofield R; Fabre JW
Transplantation; 2006 Mar; 81(6):922-6. PubMed ID: 16570018
[TBL] [Abstract][Full Text] [Related]
3. Statins induce immunosuppressive effect on heterotopic limb allografts in rat through inhibiting T cell activation and proliferation.
Nie C; Yang D; Liu G; Dong D; Ma Z; Fu H; Zhao Z; Sun Z
Eur J Pharmacol; 2009 Jan; 602(1):168-75. PubMed ID: 19041862
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effects of HMG-CoA reductase inhibitors.
Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
[TBL] [Abstract][Full Text] [Related]
5. Statins as novel immunomodulators: from cell to potential clinical benefit.
Mach F
Thromb Haemost; 2003 Oct; 90(4):607-10. PubMed ID: 14515180
[TBL] [Abstract][Full Text] [Related]
6. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
[TBL] [Abstract][Full Text] [Related]
7. Statins as a newly recognized type of immunomodulator.
Kwak B; Mulhaupt F; Myit S; Mach F
Nat Med; 2000 Dec; 6(12):1399-402. PubMed ID: 11100127
[TBL] [Abstract][Full Text] [Related]
8. IFNalpha treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression.
López P; Gutiérrez C; Suárez A
Clin Immunol; 2008 Nov; 129(2):350-9. PubMed ID: 18757244
[TBL] [Abstract][Full Text] [Related]
9. Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins.
Haendeler J; Hoffmann J; Zeiher AM; Dimmeler S
Circulation; 2004 Aug; 110(7):856-61. PubMed ID: 15289372
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory properties of statins.
Steffens S; Mach F
Semin Vasc Med; 2004 Nov; 4(4):417-22. PubMed ID: 15861323
[TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
12. Action profiles of statins and calcineurin inhibitors during human mixed lymphocyte reaction.
Takahashi HK; Iwagaki H; Yagi T; Kanke T; Liu K; Yoshino T; Tanaka N; Nishibori M
Clin Immunol; 2007 Jun; 123(3):324-32. PubMed ID: 17482516
[TBL] [Abstract][Full Text] [Related]
13. The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.
Kwak B; Mulhaupt F; Veillard N; Pelli G; Mach F
Swiss Med Wkly; 2001 Jan; 131(3-4):41-6. PubMed ID: 11219190
[TBL] [Abstract][Full Text] [Related]
14. Statin-induced immunomodulatory effects on human T cells in vivo.
Fehr T; Kahlert C; Fierz W; Joller-Jemelka HI; Riesen WF; Rickli H; Wüthrich RP; Ammann P
Atherosclerosis; 2004 Jul; 175(1):83-90. PubMed ID: 15186950
[TBL] [Abstract][Full Text] [Related]
15. Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomains.
Kuipers HF; Biesta PJ; Groothuis TA; Neefjes JJ; Mommaas AM; van den Elsen PJ
Hum Immunol; 2005 Jun; 66(6):653-65. PubMed ID: 15993711
[TBL] [Abstract][Full Text] [Related]
16. The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease.
Ráki M; Molberg O; Tollefsen S; Lundin KE; Sollid LM
Clin Exp Immunol; 2005 Nov; 142(2):333-40. PubMed ID: 16232221
[TBL] [Abstract][Full Text] [Related]
17. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells.
Narumiya H; Sasaki S; Kuwahara N; Irie H; Kusaba T; Kameyama H; Tamagaki K; Hatta T; Takeda K; Matsubara H
Cardiovasc Res; 2004 Nov; 64(2):331-6. PubMed ID: 15485693
[TBL] [Abstract][Full Text] [Related]
19. Can the potential benefits of statins in general medical practice be extrapolated to liver transplantation?
Neal DA; Alexander GJ
Liver Transpl; 2001 Dec; 7(12):1009-14. PubMed ID: 11753902
[TBL] [Abstract][Full Text] [Related]
20. Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects?
Maher BM; Dhonnchu TN; Burke JP; Soo A; Wood AE; Watson RW
J Leukoc Biol; 2009 Jan; 85(1):186-93. PubMed ID: 18840670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
